Benchmark helps deliver improved healthcare products and welfare services to the global aquaculture and livestock industries. Rising demand from clients for its products and services to manage sustainability practice and performance underlines BMK's opportunity for significant organic and external growth.

02 Mar 2023

Benchmark Holdings - Q1 Results - Investor Presentation video - 1 March 2023

Benchmark Holdings plc, the aquaculture biotechnology company, conducted an investor presentation following publication of their Q1 results for the three month period ended 31 December 2022.

Trond Williksen, CEO, and Septima Maguire, CFO, took investors through the highlights of the period and a detailed financial review by business area (Genetics, Advanced Nutrition, Health). The management discussed the significant uplift in the Health division with increasing adoption of Ectosan®Vet and CleanTreat®, and also touched on current trading & outlook. The team also took investor questions which covered areas such as the growth of the aquaculture industry and potential de-listing from AIM.

The full video recording is available below, divided into chapters:
0:00:03 Introduction & summary Q1 highlights
0:05:25 Business area highlights (Genetics, Advanced Nutrition, Health)
0:17:31 Financial Review
0:27:22 Current trading & outlook
0:30:31 Conclusion & Benchmark's unique value proposition
0:33:28 Questions & Answers

Return to Benchmark Holdings

Register to be first

Get research on the companies that interest you straight to your inbox

Equity Development is a partner to successful companies looking to enhance their investor relations. Our top-rated analysts produce best in class investment research. Based in London, UK, we help our clients connect with investors via presentations and interviews.

Equity Development Limited 2nd Floor, Park House, 16-18 Finsbury Circus, London, EC2M 7EB

Website design & development by Breckenridge